Abstract 13322: Patients With a High Genetic Risk Score for Coronary Artery Disease May Receive Greater Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial

Introduction: Polygenic risk scores (PRS) summarize disease risk over a number of genetic loci into a single risk score for each patient (pt), providing a promising tool for risk stratification and...